Description

Glibenclamide, Metformin & Pioglitazone Tablets (Triple FDC)

Healthy Inc is a specialized global supplier and exporter of advanced endocrinology, metabolic-rescue, and complex multi-API antidiabetic therapeutics. We provide ultra-high-purity, kinetically synchronized Glibenclamide, Metformin Hydrochloride & Pioglitazone Film-Coated / Bilayer Tablets, manufactured in WHO–GMP certified, high-precision modified-release oral solid dosage facilities. This “Triple-Mechanism Glycemic Control System” is a massive-volume, highly critical export to diabetic care clinics, internal medicine networks, tertiary care hospitals, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, final oral intervention for severe Type 2 Diabetes Mellitus before the initiation of exogenous insulin therapy.

Product Overview

This highly advanced formulation represents the pinnacle of oral diabetic management. It deploys three distinct, complementary mechanisms to force down HbA1c levels: stimulating the pancreas to produce more insulin, forcing the liver to stop producing excess sugar, and chemically unlocking the body’s muscle and fat cells so they can absorb glucose.

The “Insulin Secretagogue, Sensitizer & Hepatic Restrictor” Specialist:

• Mechanism 1 (The Beta-Cell Stimulator – Glibenclamide): Glibenclamide (a Sulfonylurea) works directly on the pancreas. It binds to ATP-sensitive potassium channels on the pancreatic beta cells, forcing them to depolarize and violently squeeze out surges of endogenous insulin to handle post-meal blood sugar spikes.
• Mechanism 2 (The Hepatic Anchor – Metformin): While the pancreas pumps insulin, Metformin (a Biguanide) works in the liver. It activates the AMPK enzyme to drastically suppress hepatic gluconeogenesis, preventing the liver from dumping stored sugar into the bloodstream while the patient is fasting or sleeping.
• Mechanism 3 (The Peripheral Sensitizer – Pioglitazone): In severe diabetes, the patient’s cells are “deaf” to insulin. Pioglitazone (a Thiazolidinedione) is a highly potent PPAR-gamma receptor agonist. It fundamentally alters gene transcription in muscle and adipose (fat) tissue, drastically reducing insulin resistance and forcing the cells to “listen” to the insulin produced by the Glibenclamide, allowing massive amounts of glucose to be cleared from the blood.

Product Composition & Strength

We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.

*Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Endocrinology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Macro/Micro Tri-Active Content Uniformity (CRITICAL COMPLIANCE): Combining three drastically different molecules into a single, swallowable pill is a severe thermodynamic and blending challenge. If Content Uniformity (CU) fails, a patient could ingest a concentrated pocket of Glibenclamide, resulting in severe, fatal hypoglycemia. Our endocrinology suites utilize highly advanced high-shear wet granulation, geometric dilution, and intensive HPLC batch-testing to guarantee that every single tablet delivers the exact milligram ratio required for safe, predictable metabolic control.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly aggressive management of severe metabolic dysfunction:

• Refractory Type 2 Diabetes Mellitus: For patients with uncontrolled blood sugar and high HbA1c levels who have failed to achieve glycemic targets on dual therapy (e.g., Metformin + Sulfonylurea or Metformin + Pioglitazone).
• High Insulin Resistance: Specifically utilized in diabetic profiles characterized by severe obesity and deep cellular insulin resistance, delaying the absolute need for injectable insulin.

Dosage & Administration

Recommended Dosage (Strictly as per Endocrinologist Guidelines):

• Standard Adult Dosing: One tablet taken once or twice daily, heavily dependent on the patient’s prior dosing history and current HbA1c levels.
• Administration (The Hypoglycemia & GI Rule): MUST be taken exactly with meals. Taking this medication on an empty stomach will trigger severe, life-threatening low blood sugar (due to Glibenclamide) and violent gastrointestinal distress (due to Metformin).

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Congestive Heart Failure – Pioglitazone): Thiazolidinediones like Pioglitazone cause severe fluid retention. This can exacerbate or trigger catastrophic Congestive Heart Failure (CHF). It is absolutely contraindicated in patients with NYHA Class III or IV heart failure.
• BLACK BOX WARNING (Lactic Acidosis – Metformin): Metformin accumulation can trigger highly fatal Lactic Acidosis. This risk massively increases in patients with renal impairment. The FDC is strictly contraindicated in patients with severe kidney disease (eGFR < 30).
• Severe Hypoglycemia (Glibenclamide): Glibenclamide is a long-acting sulfonylurea. It forces insulin release regardless of whether the patient has eaten. Skipping a meal while on this drug can plunge the patient into a hypoglycemic coma.
• Bladder Cancer Risk: Long-term use of Pioglitazone has been statistically linked to an increased risk of bladder cancer. It is contraindicated in patients with a history of bladder malignancies.
• Bone Fractures: Pioglitazone alters bone metabolism, significantly increasing the risk of atypical bone fractures, particularly in postmenopausal women.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Diabetic Care Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antidiabetics, Triple FDCs, and Content-Uniformity Assured Formulations. Whether you are looking for a reliable Government Tender Supplier for metabolic clinics in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.